vcfirmsdirectory.com

Venture capital

Aditum Bio

Aditum Bio is a biotech venture capital firm that acquires clinic-ready drug candidates and forms and operates portfolio companies to advance them through early clinical trials.

Oakland · CambridgeRegistered · Oakland
New investments · 12 months
Fund vehiclesPublic
3
3 active · US private fund
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 8 Nov 2026, 05:05 CETSources: aditumbio.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round Aditum Bio joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is Aditum Bio right for your round?

Is Aditum Bio a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
3
3 active · US private fund
SEC adviser filings
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

ADITUM BIO FUND 3, L.P.US private fund · Active · United States · $413.7M gross assets · filed 31 Mar 2026
ADITUM BIO FUND 2, L.P.US private fund · Active · United States · $179.6M gross assets · filed 31 Mar 2026
ADITUM BIO FUND 1, L.P.US private fund · Active · United States · $179.5M gross assets · filed 31 Mar 2026
Deployed (new cheques)
Next fund expected

Latest investments

BetaRounds Aditum Bio joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

1 round in the last 12 months

Round sizes, Aditum Bio’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

Kalexo BioVersanisOblenio BioVitalli BioTrames Bio

Portfolio and exits

Every company Aditum Bio backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where Aditum Bio puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet Aditum Bio

Events where Aditum Bio’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet Aditum Bio’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

25 Jun 2026New deal
31 Mar 2026Fund filingForm ADV filed by ADITUM BIO MANAGEMENT COMPANY, LLC: 3 private funds, $772.8M in gross assets.SEC Form ADV · public record

Founders also look at

Frequently asked questions

Aditum Bio is based in Oakland, United States. It also has an office in Cambridge.

3 fund vehicles are on public registers (SEC adviser filings), including ADITUM BIO FUND 3, L.P., ADITUM BIO FUND 2, L.P. and ADITUM BIO FUND 1, L.P.

Sectors: Biotech, Life sciences. From the firm’s own website.

Focuses on the translational stage of drug development, acquiring promising clinic-ready therapies for underserved patient populations. In-house R&D experts and a lean operating model speed company formation and move candidates into Phase 2 trials, using digital tools to run trials efficiently and cut costs. From the firm’s own website.

Aditum Bio lists 5 portfolio companies on its website: Kalexo Bio, Versanis, Oblenio Bio, Vitalli Bio and Trames Bio.

Know before Aditum Bio’s next round is announced.

PRO tracks Aditum Bio’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

Aditum BioGet Aditum Bio’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.